Diplomat Specialty Pharmacy has signed an agreement with a provider of acquisition and management services for oral cancer drugs that the companies said would allow for better access to the drugs and related programs.
A drug made by Amgen delayed the spread of prostate cancer to the bones in men with the disease and prolonged the survival of men with the condition, according to results of a late-stage clinical trial.
Acai berry, cumin, herbal tea, turmeric and long-term use of garlic may negatively impact chemotherapy treatment, according to a new report released Wednesday that originally was presented at the American Society of Clinical Oncology meeting in Chicago this summer.
Prince of Peace Enterprises on Monday announced its sponsorship of the 2011 Susan G. Komen Race for the Cure Global, taking place in Washington, D.C., June 4 at the Capitol Mall in support of its external analgesic Tiger Balm.
Breast cancer survivors who experience large weight gain have an increased risk of death after diagnosis, according to research released Tuesday by scientists at the Kaiser Permanente Division of Research in Oakland, Calif.
3Rx Skin Therapy has announced the introduction of a new skin care line to help repair and rejuvenate skin damaged by such cancer treatments as chemotherapy and radiation, and other dry skin issues caused by medical conditions.
A subsidiary of Watson Pharmaceuticals has entered a licensing agreement with a subsidiary of Hungarian drug maker Richter to develop and market a drug for uterine fibroids, the two companies said Thursday.
Chemotherapy drugs made by Johnson & Johnson and Merck will become the standard second-line treatment for ovarian cancer within the decade, replacing a treatment made by Bristol-Myers Squibb and generic versions, according to a new report by market research firm Decision Resources.